Treatment of advanced bone marrow neoplasms with ifosfamide combinations.

Abstract

Ifosfamide, in combination with other cytostatics, was given to 15 patients with advanced neoplasia derived from bone marrow cells. A response to therapy was obtained in 8 patients. It is suggested that ifosfamide, in combination with other drugs, deserves larger trials in the treatment of advanced bone marrow neoplasia.

• Authors: B Norberg, J Holm, E Winqvist, A Wahlin
• Journal: Scandinavian journal of haematology (Scand J Haematol) Vol. 32 Issue 1 Pg. 95-100 (Jan 1984) ISSN: 0036-553X [Print] Denmark
• PMID: 6582586 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Vincristine
• Vinblastine
• Doxorubicin
• Cyclophosphamide
• Ifosfamide
• Prednisone

Topics

• Adolescent
• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Bone Marrow (drug effects, pathology)
• Cyclophosphamide (administration & dosage, analogs & derivatives)
• Doxorubicin (administration & dosage)
• Female
• Humans
• Ifosfamide (administration & dosage, adverse effects)
• Leukemia (drug therapy)
• Leukemia, Lymphoid (drug therapy)
• Leukemia, Myeloid, Acute (drug therapy)
• Male
• Middle Aged
• Multiple Myeloma (blood, drug therapy)
• Prednisone (administration & dosage)
• Vinblastine (administration & dosage)
• Vincristine (administration & dosage)